{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:35:14Z","timestamp":1763757314926,"version":"3.45.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bulcan.2025.07.014","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T19:23:25Z","timestamp":1758137005000},"page":"1438-1446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utilisation des r\u00e9servoirs d\u2019Ommaya au cours du traitement des leuc\u00e9mies aigu\u00ebs p\u00e9diatriques\u00a0: recommandations du comit\u00e9 Leuc\u00e9mies de la Soci\u00e9t\u00e9 fran\u00e7aise de lutte contre les cancers et leuc\u00e9mies de l\u2019enfant et de l\u2019adolescent (SFCE)"],"prefix":"10.1016","volume":"112","author":[{"given":"Anna\u00eblle","family":"Rousseaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Leglise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauriane","family":"Goldwirt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Beccaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimrod","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Leverger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Simon","family":"Rohrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9229-0150","authenticated-orcid":false,"given":"Marion","family":"Strullu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bulcan.2025.07.014_bib0250","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel","volume":"120","author":"Creutzig","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bulcan.2025.07.014_bib0255","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1038\/s41375-022-01714-x","article-title":"Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions","volume":"36","author":"Thastrup","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0260","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V37.3.272.272","article-title":"Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia","volume":"37","author":"Aur","year":"1971","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bulcan.2025.07.014_bib0265","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/1097-0142(197008)26:2<404::AID-CNCR2820260222>3.0.CO;2-I","article-title":"The increasing incidence of central nervous system leukemia in children (Children's Cancer Study Group A)","volume":"26","author":"Evans","year":"1970","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0270","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(197309)32:3<585::AID-CNCR2820320311>3.0.CO;2-K","article-title":"Prevention of central nervous system leukemia by irradiation","volume":"32","author":"Hustu","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2025.07.014_bib0275","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1182\/asheducation-2006.1.142","article-title":"Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment","author":"Pui","year":"2006","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.bulcan.2025.07.014_bib0280","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V92.2.411","article-title":"Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia","volume":"92","author":"Pui","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.014_bib0285","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V60.4.948.948","article-title":"Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study","volume":"60","author":"Sullivan","year":"1982","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bulcan.2025.07.014_bib0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/cdd.1984.1.169","article-title":"Implantable devices for chronic access and drug delivery to the central nervous system","volume":"1","author":"Ommaya","year":"1984","journal-title":"Cancer Drug Deliv"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.014_bib0295","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00280-024-04653-9","article-title":"Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital","volume":"93","author":"Gaietto","year":"2024","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.bulcan.2025.07.014_bib0300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2165\/00003495-199141050-00003","article-title":"Current pharmacological treatment approaches to central nervous system leukaemia","volume":"41","author":"Blaney","year":"1991","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bulcan.2025.07.014_bib0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00173684","article-title":"Pharmacologic strategies for the treatment of meningeal malignancy","volume":"14","author":"Blaney","year":"1996","journal-title":"Invest New Drugs"},{"issue":"1","key":"10.1016\/j.bulcan.2025.07.014_bib0310","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1200\/JCO.1995.13.1.177","article-title":"Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration","volume":"13","author":"Blaney","year":"1995","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.014_bib0315","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","article-title":"Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections","volume":"293","author":"Shapiro","year":"1975","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mpo.2950060304","article-title":"Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir","volume":"6","author":"Bleyer","year":"1979","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.014_bib0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/oxfordjournals.annonc.a059187","article-title":"Intrathecal chemotherapy for treatment of overt meningeal leukemia: comparison between intraventricular and traditional intralumbar route","volume":"6","author":"Iacoangeli","year":"1995","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.bulcan.2025.07.014_bib0330","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1200\/JCO.1985.3.9.1217","article-title":"Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy","volume":"3","author":"Steinherz","year":"1985","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.014_bib0335","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3171\/jns.2001.94.4.0545","article-title":"Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy","volume":"94","author":"Field","year":"2001","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0340","first-page":"320","article-title":"Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period","volume":"9","author":"Liumbruno","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.bulcan.2025.07.014_bib0345","unstructured":"Antibioprophylaxie en chirurgie et m\u00e9decine interventionnelle [Internet]. Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie et de r\u00e9animation [cit\u00e9 9\u00a0mars 2025]. Disponible sur\u00a0: https:\/\/sfar.org\/download\/antibioprophylaxie-en-chirurgie-et-medecine-interventionnelle\/."},{"issue":"8","key":"10.1016\/j.bulcan.2025.07.014_bib0350","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1056\/NEJM197508212930807","article-title":"Cell kinetics and practical consequences for therapy of acute leukemia","volume":"293","author":"Mauer","year":"1975","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0355","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1097-0142(197809)42:3<1255::AID-CNCR2820420334>3.0.CO;2-M","article-title":"Proliferative kinetics of the leukemic cells in meningeal leukemia","volume":"42","author":"Tsuchiya","year":"1978","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.bulcan.2025.07.014_bib0360","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1172\/JCI106181","article-title":"Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates","volume":"48","author":"Hryniuk","year":"1969","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.bulcan.2025.07.014_bib0365","first-page":"1641","article-title":"Methotrexate cytotoxicity for L5178Y\/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viability","volume":"42","author":"Keefe","year":"1982","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.bulcan.2025.07.014_bib0370","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V51.5.835.835","article-title":"\u201cConcentration\u00a0\u00d7\u00a0Time\u201d methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms","volume":"51","author":"Bleyer","year":"1978","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bulcan.2025.07.014_bib0375","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM197310112891503","article-title":"Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia","volume":"289","author":"Bleyer","year":"1973","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0380","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3324\/haematol.2020.268565","article-title":"Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia","volume":"107","author":"Mateos","year":"2021","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.bulcan.2025.07.014_bib0385","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1200\/JCO.1989.7.11.1741","article-title":"Variability in the disposition of intraventricular methotrexate: a proposal for rational dosing","volume":"7","author":"Strother","year":"1989","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.014_bib0390","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/clpt.1984.120","article-title":"Cytosine arabinoside cerebrospinal fluid kinetics","volume":"35","author":"Zimm","year":"1984","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.014_bib0395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40272-018-0298-9","article-title":"The use of ommaya reservoirs to deliver central nervous system-directed chemotherapy in childhood acute lymphoblastic leukaemia","volume":"20","author":"Wilson","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"1","key":"10.1016\/j.bulcan.2025.07.014_bib0400","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00586-017-5387-x","article-title":"Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use","volume":"28","author":"Schlatter","year":"2019","journal-title":"Eur Spine J"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0405","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5694\/j.1326-5377.2000.tb125570.x","article-title":"Potential for patient harm from intrathecal administration of preserved solutions","volume":"173","author":"Hetherington","year":"2000","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.bulcan.2025.07.014_bib0410","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/WNL.33.8.1032","article-title":"Paraparesis following intrathecal chemotherapy","volume":"33","author":"Hahn","year":"1983","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.014_bib0415","first-page":"328","article-title":"Intrathecal methotrexate containing the preservative benzyl alcohol erroneously administered in pediatric leukemia patients: clinical course and preventive process","volume":"25","author":"Messinger","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.bulcan.2025.07.014_bib0420","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11060-014-1531-1","article-title":"Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472\u00a0intraventricular drug administrations in 98\u00a0patients","volume":"120","author":"Peyrl","year":"2014","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0425","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ymgme.2018.05.003","article-title":"Best practices for the use of intracerebroventricular drug delivery devices","volume":"124","author":"Slavc","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bulcan.2025.07.014_bib0430","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","article-title":"Intracerebroventricular delivery as a safe, long-term route of drug administration","volume":"67","author":"Cohen-Pfeffer","year":"2017","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0435","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jinf.2013.12.002","article-title":"Ommaya reservoir-related infections: clinical manifestations and treatment outcomes","volume":"68","author":"Szvalb","year":"2014","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.014_bib0440","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jinf.2013.11.014","article-title":"Ommaya reservoir infections: a 16-year retrospective analysis","volume":"68","author":"Mead","year":"2014","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.bulcan.2025.07.014_bib0445","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/21548331.2015.1017438","article-title":"Pathogenesis, clinical course and neuro-radiological signs of Proprionibacterium acnes cerebritis: case report and literature review","volume":"43","author":"Yakhkind","year":"2015","journal-title":"Hosp Pract (1995)"},{"key":"10.1016\/j.bulcan.2025.07.014_bib0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12879-014-0712-z","article-title":"A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections","volume":"15","author":"Ramanan","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.bulcan.2025.07.014_bib0455","first-page":"147","article-title":"Prevention of device-related infections in patients with cancer: current practice and future horizons","volume":"73","author":"Viola","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.014_bib0460","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.bulcan.2025.07.014_bib0465","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/14787210.2021.1866544","article-title":"Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies","volume":"19","author":"Hasbun","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.014_bib0470","doi-asserted-by":"crossref","first-page":"ofab216","DOI":"10.1093\/ofid\/ofab216","article-title":"Ventriculitis: a severe complication of central nervous system infections","volume":"8","author":"Luque-Paz","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bulcan.2025.07.014_bib0475","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1016\/j.wneu.2018.08.138","article-title":"The role of intraventricular antibiotics in the treatment of nosocomial ventriculitis\/meningitis from gram-negative pathogens: a systematic review and meta-analysis","volume":"120","author":"Karvouniaris","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.bulcan.2025.07.014_bib0480","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.wneu.2016.06.022","article-title":"The role of endoscopic lavage in recalcitrant multidrug-resistant gram-negative ventriculitis among neurosurgical patients","volume":"93","author":"Kumar","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.bulcan.2025.07.014_bib0485","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clineuro.2016.05.010","article-title":"Effectiveness of neuroendoscopic ventricular irrigation for ventriculitis","volume":"146","author":"Terada","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.014_bib0245","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3171\/2020.5.PEDS2063","article-title":"Outcome improvement in cerebral ventriculitis after ventricular irrigation: a prospective controlled study","volume":"26","author":"Al Menabbawy","year":"2020","journal-title":"J Neurosurg Pediatr"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125003868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125003868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:31:03Z","timestamp":1763757063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125003868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0007455125003868"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.07.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilisation des r\u00e9servoirs d\u2019Ommaya au cours du traitement des leuc\u00e9mies aigu\u00ebs p\u00e9diatriques\u00a0: recommandations du comit\u00e9 Leuc\u00e9mies de la Soci\u00e9t\u00e9 fran\u00e7aise de lutte contre les cancers et leuc\u00e9mies de l\u2019enfant et de l\u2019adolescent (SFCE)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}